MUC1-peptide-pulsed dendritic cell vaccine (Fudan University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMUC1-peptide-pulsed dendritic cell vaccine (Fudan University)

Drug Alias NameMUC1 peptide vaccine program

ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionMucin-1 modulators

TargetsMucin-1

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesFudan University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesFudan University

Active IndicationsN/A

Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A